Addus (ADUS) Q1 2026 Earnings Transcript

Addus reported Q1 revenue of $363.6 million, up 7.7%, with adjusted EPS of $1.62 (+14.1%) and adjusted EBITDA of $44.5 million (+9.7%). Cash flow from operations surged to $52.4 million, bank debt fell $30 million to $94.3 million, and the company closed a new Indiana entry deal while signaling more M&A capacity. Management also cited favorable rate support in Illinois and Texas, improving hiring trends, and continued rollout of its caregiver app, though weather hurt Q1 personal care volumes modestly.

Analysis

ADUS is transitioning from a “rate-only” story to a more durable operating compounder: the key second-order effect is that higher state reimbursement plus better collections and G&A leverage are converting revenue growth into cash, which materially expands M&A optionality. That matters because the company is now close enough to its leverage ceiling that every incremental dollar of free cash flow can be redeployed into accretive density, not just balance-sheet repair. The market is likely underappreciating how quickly a cleaned-up balance sheet can translate into a self-reinforcing acquisition cycle in fragmented home care.

The bigger surprise is not the quarter itself, but the improving quality of growth. Personal care volume was pressured by weather, yet service intensity and authorization fill rates kept rising, suggesting process improvements are offsetting census noise; if that continues, the model can grow even without heroic client adds. The caregiver app is the real operating lever here: it should improve retention, scheduling efficiency, and hours-per-client, which means margin expansion can happen even if wage inflation stays near current levels. That is a better setup than pure headcount-driven growth, because it reduces dependence on a tight labor market.

On the strategic side, Indiana is less about a single acquisition and more about proving the company can replicate its playbook in a new state with managed Medicaid and regional adjacency. If the second Indiana deal closes, ADUS will have demonstrated that it can enter with enough scale to be relevant immediately, which should widen the set of targets and reduce execution risk on larger deals. The contrarian angle is that the stock may still be valued as a steady healthcare services name, while the business is increasingly behaving like a consolidator with embedded rate protection, compliance advantage, and optionality from regulatory scrutiny of smaller operators. Key risks are political: any delay in Illinois/New Mexico funding, or a reversal in CMS sentiment, would hit the multiple before it hits earnings.

Key Decisions for Investors

• Go long ADUS on 3-6 month horizon; upside comes from sustained >12% EBITDA margins plus M&A optionality, while downside is limited by balance-sheet deleveraging and cash generation.
• Add to ADUS on pullbacks tied to any near-term noise around census or weather; those are likely transitory and should fade over the next 1-2 quarters as app rollout and Illinois momentum show through.
• Pair trade: long ADUS / short a lower-quality home care operator with weaker compliance and balance sheet; the spread should widen if regulators intensify fraud-and-abuse enforcement over the next 6-12 months.
• Use call spreads in ADUS into the next 1-2 earnings windows if management confirms closing of the second Indiana deal; the market may re-rate the stock on proof that larger-scale M&A is repeatable.
• Trim if Illinois or New Mexico funding commentary deteriorates materially, since the thesis is increasingly dependent on state-level rate support sustaining same-store growth.